These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1080 related items for PubMed ID: 17785729

  • 1. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
    Sampath L, Kwon S, Ke S, Wang W, Schiff R, Mawad ME, Sevick-Muraca EM.
    J Nucl Med; 2007 Sep; 48(9):1501-10. PubMed ID: 17785729
    [Abstract] [Full Text] [Related]

  • 2. Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts.
    McLarty K, Cornelissen B, Cai Z, Scollard DA, Costantini DL, Done SJ, Reilly RM.
    J Nucl Med; 2009 Aug; 50(8):1340-8. PubMed ID: 19617342
    [Abstract] [Full Text] [Related]

  • 3. Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates.
    Razumienko EJ, Chen JC, Cai Z, Chan C, Reilly RM.
    J Nucl Med; 2016 Mar; 57(3):444-52. PubMed ID: 26429962
    [Abstract] [Full Text] [Related]

  • 4. Near infrared fluorescent optical imaging for nodal staging.
    Sampath L, Wang W, Sevick-Muraca EM.
    J Biomed Opt; 2008 Mar; 13(4):041312. PubMed ID: 19021320
    [Abstract] [Full Text] [Related]

  • 5. A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.
    Reilly RM, Kiarash R, Sandhu J, Lee YW, Cameron RG, Hendler A, Vallis K, Gariépy J.
    J Nucl Med; 2000 May; 41(5):903-11. PubMed ID: 10809207
    [Abstract] [Full Text] [Related]

  • 6. MicroSPECT/CT imaging of co-expressed HER2 and EGFR on subcutaneous human tumor xenografts in athymic mice using ¹¹¹In-labeled bispecific radioimmunoconjugates.
    Razumienko E, Dryden L, Scollard D, Reilly RM.
    Breast Cancer Res Treat; 2013 Apr; 138(3):709-18. PubMed ID: 23525982
    [Abstract] [Full Text] [Related]

  • 7. A kit to prepare (111)In-DTPA-trastuzumab (Herceptin) Fab fragments injection under GMP conditions for imaging or radioimmunoguided surgery of HER2-positive breast cancer.
    Scollard DA, Chan C, Holloway CM, Reilly RM.
    Nucl Med Biol; 2011 Jan; 38(1):129-36. PubMed ID: 21220136
    [Abstract] [Full Text] [Related]

  • 8.
    Chopra A.
    ; 2004 Jan. PubMed ID: 20641695
    [Abstract] [Full Text] [Related]

  • 9. Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using (111)In-trastuzumab (Herceptin) Fab fragments.
    Tang Y, Wang J, Scollard DA, Mondal H, Holloway C, Kahn HJ, Reilly RM.
    Nucl Med Biol; 2005 Jan; 32(1):51-8. PubMed ID: 15691661
    [Abstract] [Full Text] [Related]

  • 10. Small-animal SPECT/CT of HER2 and HER3 expression in tumor xenografts in athymic mice using trastuzumab Fab-heregulin bispecific radioimmunoconjugates.
    Razumienko EJ, Scollard DA, Reilly RM.
    J Nucl Med; 2012 Dec; 53(12):1943-50. PubMed ID: 23096164
    [Abstract] [Full Text] [Related]

  • 11. Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.
    McLarty K, Cornelissen B, Scollard DA, Done SJ, Chun K, Reilly RM.
    Eur J Nucl Med Mol Imaging; 2009 Jan; 36(1):81-93. PubMed ID: 18712381
    [Abstract] [Full Text] [Related]

  • 12. Conjugation with (111)In-DTPA-poly(ethylene glycol) improves imaging of anti-EGF receptor antibody C225.
    Wen X, Wu QP, Ke S, Ellis L, Charnsangavej C, Delpassand AS, Wallace S, Li C.
    J Nucl Med; 2001 Oct; 42(10):1530-7. PubMed ID: 11585869
    [Abstract] [Full Text] [Related]

  • 13. Antitumor effects and normal-tissue toxicity of 111In-nuclear localization sequence-trastuzumab in athymic mice bearing HER-positive human breast cancer xenografts.
    Costantini DL, McLarty K, Lee H, Done SJ, Vallis KA, Reilly RM.
    J Nucl Med; 2010 Jul; 51(7):1084-91. PubMed ID: 20554744
    [Abstract] [Full Text] [Related]

  • 14. Comparative biodistribution of imaging agents for in vivo molecular profiling of disseminated prostate cancer in mice bearing prostate cancer xenografts: focus on 111In- and 125I-labeled anti-HER2 humanized monoclonal trastuzumab and ABY-025 affibody.
    Malmberg J, Sandström M, Wester K, Tolmachev V, Orlova A.
    Nucl Med Biol; 2011 Nov; 38(8):1093-102. PubMed ID: 22137850
    [Abstract] [Full Text] [Related]

  • 15. On the selection of a tracer for PET imaging of HER2-expressing tumors: direct comparison of a 124I-labeled affibody molecule and trastuzumab in a murine xenograft model.
    Orlova A, Wållberg H, Stone-Elander S, Tolmachev V.
    J Nucl Med; 2009 Mar; 50(3):417-25. PubMed ID: 19223403
    [Abstract] [Full Text] [Related]

  • 16. ¹¹¹In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer.
    Fasih A, Fonge H, Cai Z, Leyton JV, Tikhomirov I, Done SJ, Reilly RM.
    Breast Cancer Res Treat; 2012 Aug; 135(1):189-200. PubMed ID: 22736376
    [Abstract] [Full Text] [Related]

  • 17. Preclinical evaluation of [¹¹¹ In]-DOTA-trastuzumab for clinical trials.
    Alirezapour B, Jalilian AR, Rajabifar S, Mirzaii M, Moradkhani S, Pouladi M, Aslani G.
    J Cancer Res Ther; 2014 Aug; 10(1):112-20. PubMed ID: 24762497
    [Abstract] [Full Text] [Related]

  • 18. Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe.
    Li C, Wang W, Wu Q, Ke S, Houston J, Sevick-Muraca E, Dong L, Chow D, Charnsangavej C, Gelovani JG.
    Nucl Med Biol; 2006 Apr; 33(3):349-58. PubMed ID: 16631083
    [Abstract] [Full Text] [Related]

  • 19. Preparation and In Vitro and In Vivo Characterization of the Tumor-specific Antigen-derived Peptide as a Potential Candidate for Targeting Human Epidermal Growth Factor Receptor 2-positive Breast Carcinomas.
    Okarvi SM, Aljammaz I.
    Anticancer Res; 2018 May; 38(5):2823-2830. PubMed ID: 29715105
    [Abstract] [Full Text] [Related]

  • 20. Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies.
    Terwisscha van Scheltinga AG, van Dam GM, Nagengast WB, Ntziachristos V, Hollema H, Herek JL, Schröder CP, Kosterink JG, Lub-de Hoog MN, de Vries EG.
    J Nucl Med; 2011 Nov; 52(11):1778-85. PubMed ID: 21990576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.